Kim_2009_J.Pharmacol.Sci_111_110

Reference

Title : Gluco-obtusifolin and its aglycon, obtusifolin, attenuate scopolamine-induced memory impairment - Kim_2009_J.Pharmacol.Sci_111_110
Author(s) : Kim DH , Hyun SK , Yoon BH , Seo JH , Lee KT , Cheong JH , Jung SY , Jin C , Choi JS , Ryu JH
Ref : J Pharmacol Sci , 111 :110 , 2009
Abstract :

In the present study, we assessed the effects of gluco-obtusifolin, isolated from the seeds of Cassia obtusifolia L., and its aglycone, obtusifolin, on the learning and memory impairments induced by scopolamine using the passive avoidance and the Morris water maze tasks in mice. Gluco-obtusifolin (1, 2, and 4 mg/kg, p.o.) and obtusifolin (0.25, 0.5, 1, and 2 mg/kg, p.o.) significantly reversed scopolamine-induced cognitive impairments in the passive avoidance test (P<0.05). Moreover, gluco-obtusifolin (2 mg/kg, p.o.) and obtusifolin (0.5 mg/kg, p.o.) improved escape latencies, swimming times in the target quadrant, and crossing numbers in the zone where the platform previously existed in the Morris water maze test. In the acetylcholinesterase assay, gluco-obtusifolin and obtusifolin were found to inhibit acetylcholinesterase activity in vitro (IC(50) = 37.2 and 18.5 microM, respectively) and ex vivo. These results suggest that gluco-obtusifolin and its aglycone may be useful for the treatment of cognitive impairment, and that its beneficial effects are mediated, in part, by the enhancement of cholinergic signaling.

PubMedSearch : Kim_2009_J.Pharmacol.Sci_111_110
PubMedID: 19834282

Related information

Citations formats

Kim DH, Hyun SK, Yoon BH, Seo JH, Lee KT, Cheong JH, Jung SY, Jin C, Choi JS, Ryu JH (2009)
Gluco-obtusifolin and its aglycon, obtusifolin, attenuate scopolamine-induced memory impairment
J Pharmacol Sci 111 :110

Kim DH, Hyun SK, Yoon BH, Seo JH, Lee KT, Cheong JH, Jung SY, Jin C, Choi JS, Ryu JH (2009)
J Pharmacol Sci 111 :110